VERAVera Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Vera Therapeutics, Inc. against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VERAEsta | $2.2B#9 | — | 5.4x#1 | — | — | -96.9%#8 | — | -73.5%#8 | -72.7%#3 | — | 18.5%#5 | — |
| MRNA | $91.2B#1 | — | 13.5x#6 | 46.9x#3 | -39.9%#5 | 20.8%#4 | -158.1%#3 | -41.7%#6 | -54.6%#2 | — | 817.2%#1 | — |
| TWST | $8.8B#3 | — | 19.8x#7 | 23.4x#1 | 20.3%#3 | 62.8%#1 | -36.2%#1 | -17.4%#4 | -41.4%#1 | — | 345.0%#2 | — |
| ORKA | $6.6B#6 | — | 5.9x#4 | — | — | -25.9%#5 | — | -9.5%#3 | — | — | 279.7%#3 | — |
| KYMR | $10.9B#2 | — | 6.7x#5 | 276.9x#5 | -16.7%#4 | 39.1%#2 | -891.1%#5 | 19.3%#1 | — | — | — | — |
| VKTX | $3.3B#8 | — | 5.7x#2 | — | — | -227.1%#9 | — | -61.1%#7 | — | — | — | — |
| PRAX | $7.8B#5 | — | 5.8x#3 | — | -100.0%#6 | -65.6%#7 | — | -22.6%#5 | — | — | 54.3%#4 | — |
| RYTM | $6.0B#7 | — | 68.0x#8 | 31.5x#2 | 45.8%#2 | 24.6%#3 | -101.2%#2 | -0.2%#2 | -127.5%#4 | — | -24.1%#6 | — |
| CYTK | $8.7B#4 | — | — | 98.5x#4 | 376.6%#1 | -33.2%#6 | -695.4%#4 | — | — | — | — | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice